Jiangsu Honghui Equity Investment Management
Shanghaihlc.com.cn
Overview
Jiangsu Honghui Equity Investment Management, also known as Honghui Capital (HLC), is an investment institution focused on the 'Healthy Living' sector, investing in companies related to the biological industry chain, health equipment, and healthy consumption.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Approaching.AI | May 2026 | Pre Seed | Co-investor |
| Jiangsu Asia Electronics Technology Co., Ltd. | Apr 2022 | Early Funding | Co-investor |
| Artivila Biopharma | Mar 2021 | Seed | Lead |
| 弈柯莱生物科技(集团)股份有限公司 | Apr 2019 | Series A | Co-investor |
| Chengyi Family (橙意家人) | Nov 2014 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?